BioCentury | Oct 1, 2020
Distillery Therapeutics

Calcium channel-targeting peptide to prevent hypertrophic cardiomyopathy

...M. Viola, The University of Western Australia, Crawley, Australiaemail: helena.viola@uwa.edu.au CONTACT: Livia C. Hool, same affiliation as aboveemail: livia.hool@uwa.edu.au Claire Quang University of Western Australia Calcium...
BioCentury | Aug 22, 2019
Distillery Therapeutics

Pretreatment with STAT1 activators, IL-10 blocker to improve response to checkpoint inhibitors

...published online July 17, 2019 doi:10.1126/scitranslmed.aav7816 CONTACT: W. Joost Lesterhuis, University of Western Australia, Perth, Australia e-mail: willem.lesterhuis@uwa.edu.au Sandi Wong University of Western Australia Cytotoxic...
BioCentury | Aug 17, 2018
Targets & Mechanisms

RNA party

...appeared to be a very effective degradation.” Leedman is a professor of medicine at the University of Western Australia...
...Ltd., Perth, Australia Shire plc (NASDAQ:SHPG; LSE:SHP), Dublin, Ireland Translate Bio Inc. (NASDAQ:TBIO), Lexington, Mass. University of Western Australia...
BioCentury | Oct 3, 2017
Distillery Therapeutics

Cancer

...al. Sci. Transl. Med. ; published online Aug. 9, 2017 doi:10.1126/scitranslmed.aam8060 CONTACT: Wallace Y. Langdon, University of Western Australia...
BioCentury | Feb 22, 2017
Distillery Techniques

Drug platforms

...published online Feb. 13, 2017 doi:10.1073/pnas.1612927114 CONTACT: Alice Vrielink, University of Western Australia, Crawley, Australia email: alice.vrielink@uwa.edu.au Hongjiang Li University of Western Australia Lipid...
BioCentury | Nov 1, 2016
Distillery Therapeutics

Infectious disease

...Med. Chem .; published online Sept. 19, 2016 doi: 10.1021/acs.jmedchem.6b00442 CONTACT: Matthew J. Piggott, The University of Western Australia...
BioCentury | Oct 5, 2015
Company News

BioMarin, Sarepta Therapeutics musculoskeletal news

...which both claim methods of using exon 51 skipping antisense oligonucleotides to treat DMD. The University of Western Australia...
BioCentury | Oct 1, 2015
Company News

PTAB favors BioMarin over Sarepta in DMD ruling

...which both claim methods of using exon 51 skipping antisense oligonucleotides to treat DMD. The University of Western Australia...
BioCentury | Mar 13, 2014
Cover Story

Killer targets in metastasis

...The team also included scientists from Medical University Innsbruck , Brown University , The University of Western Australia...
...of North Carolina at Chapel Hill Eshelman School of Pharmacy , Chapel Hill, N.C. The University of Western Australia...
BioCentury | Feb 20, 2014
Cover Story

Europe's upwelling

...of Texas Southwestern Medical Center; The University of Utah $8.2 Sarepta Therapeutics Inc. (NASDAQ:SRPT) The University of Western Australia...
Items per page:
1 - 10 of 18
BioCentury | Oct 1, 2020
Distillery Therapeutics

Calcium channel-targeting peptide to prevent hypertrophic cardiomyopathy

...M. Viola, The University of Western Australia, Crawley, Australiaemail: helena.viola@uwa.edu.au CONTACT: Livia C. Hool, same affiliation as aboveemail: livia.hool@uwa.edu.au Claire Quang University of Western Australia Calcium...
BioCentury | Aug 22, 2019
Distillery Therapeutics

Pretreatment with STAT1 activators, IL-10 blocker to improve response to checkpoint inhibitors

...published online July 17, 2019 doi:10.1126/scitranslmed.aav7816 CONTACT: W. Joost Lesterhuis, University of Western Australia, Perth, Australia e-mail: willem.lesterhuis@uwa.edu.au Sandi Wong University of Western Australia Cytotoxic...
BioCentury | Aug 17, 2018
Targets & Mechanisms

RNA party

...appeared to be a very effective degradation.” Leedman is a professor of medicine at the University of Western Australia...
...Ltd., Perth, Australia Shire plc (NASDAQ:SHPG; LSE:SHP), Dublin, Ireland Translate Bio Inc. (NASDAQ:TBIO), Lexington, Mass. University of Western Australia...
BioCentury | Oct 3, 2017
Distillery Therapeutics

Cancer

...al. Sci. Transl. Med. ; published online Aug. 9, 2017 doi:10.1126/scitranslmed.aam8060 CONTACT: Wallace Y. Langdon, University of Western Australia...
BioCentury | Feb 22, 2017
Distillery Techniques

Drug platforms

...published online Feb. 13, 2017 doi:10.1073/pnas.1612927114 CONTACT: Alice Vrielink, University of Western Australia, Crawley, Australia email: alice.vrielink@uwa.edu.au Hongjiang Li University of Western Australia Lipid...
BioCentury | Nov 1, 2016
Distillery Therapeutics

Infectious disease

...Med. Chem .; published online Sept. 19, 2016 doi: 10.1021/acs.jmedchem.6b00442 CONTACT: Matthew J. Piggott, The University of Western Australia...
BioCentury | Oct 5, 2015
Company News

BioMarin, Sarepta Therapeutics musculoskeletal news

...which both claim methods of using exon 51 skipping antisense oligonucleotides to treat DMD. The University of Western Australia...
BioCentury | Oct 1, 2015
Company News

PTAB favors BioMarin over Sarepta in DMD ruling

...which both claim methods of using exon 51 skipping antisense oligonucleotides to treat DMD. The University of Western Australia...
BioCentury | Mar 13, 2014
Cover Story

Killer targets in metastasis

...The team also included scientists from Medical University Innsbruck , Brown University , The University of Western Australia...
...of North Carolina at Chapel Hill Eshelman School of Pharmacy , Chapel Hill, N.C. The University of Western Australia...
BioCentury | Feb 20, 2014
Cover Story

Europe's upwelling

...of Texas Southwestern Medical Center; The University of Utah $8.2 Sarepta Therapeutics Inc. (NASDAQ:SRPT) The University of Western Australia...
Items per page:
1 - 10 of 18